The EPOCH Study - Phase II open labelled study investigating the use of single agent eribulin and eribulin in combination with pembrolizumab in relapsed tubo-ovarian or uterine carcinosarcoma

Ho, Gwo-Yaw (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA/ERM Reference Number: 86612
Monash Health Reference: RES-23-0000-204X

Status	Active
Effective start/end date	14/04/23 → 13/04/28